Laboratory News and Research

RSS

Evaluating new approaches for rare disease research

Marcel Nelen discusses his team’s early evaluation of a new workflow for rare disease genomics.

From Illumina, Inc. 10 Sep 2026

Bruker advances whole-organism 3D imaging with enhanced tissue-clearing workflows

Bruker Corporation today announced a strategic collaboration with Translucence Biosystems, Inc., a leading provider of tissue‑clearing solutions, to expand its workflow for cleared tissue imaging.

From Bruker Nano Surfaces and Metrology 10 Sep 2026

Blood protein profiling could improve rare disease diagnosis

Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve.

9 Sep 2026

Chaotic tumor environments may trigger cancer cell invasion

In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread, and invade healthy tissue.

9 Sep 2026

Pink noise boosts brain waste clearance during sleep

During the day, waste products such as lactic acid and worn-out proteins build up in the brain. When we sleep at night, waves of cerebrospinal fluid (CSF) help to wash away this waste, keeping the brain healthy.

9 Sep 2026

New genomic language AI model excels in predicting the pathogenicity of genetic variants

More than two decades after scientists first sequenced the entire human genome - all 3 billion "letters," or base pairs, of DNA code - the meaning of much of this code remains a mystery.

9 Sep 2026

Laser-carved microvalves prevent hazardous backflow in medical microcatheters

A single cough, deep breath, or shift in posture can turn life-saving medical microcatheters into hazardous two-way streets.

9 Sep 2026

Ten minutes of slow running boosts brain function and mood

A growing body of evidence shows that exercise improves mood and cognitive function. However, much of this evidence comes from cycling, which allows researchers to precisely control exercise intensity in the laboratory.

9 Sep 2026

Early pregnancy emotions may predict childhood developmental delay risks

Pregnancy is often one of the biggest emotional and physical transitions in a woman's life. Alongside the well-known physical changes, many women also experience shifts in mood and mental health during pregnancy and after giving birth, with anxiety and depression being quite common.

9 Sep 2026

Fourier 80 Duo - Expanding access to NMR

Discover how the Fourier 80 Duo expands access to NMR with powerful benchtop performance, streamlined workflows, and expert insights from Bruker.

From Bruker BioSpin Group 9 Sep 2026

AlphaGenome Atlas maps billions of genetic changes with AI

The human genome contains approximately 3 billion DNA letters, creating more than 9 billion possible single-letter changes.

9 Sep 2026

Eppendorf launches new refrigerated Centrifuge 5811 R

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the launch of the Centrifuge 5811 R, a refrigerated, multipurpose benchtop centrifuge designed to support a wide range of laboratory workflows. It builds on the proven performance and versatility of the Centrifuge 5810 R.

From Eppendorf 9 Sep 2026

Study identifies 14 egg-layer gene variants linked to female infertility

Researchers determine 14 variants in the egg's protective layer associated with female infertility which can affect assisted reproductive technology outcomes.

8 Sep 2026

Researchers use an experimental drug to reverse the effects of systemic sclerosis

Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in JCI Insight.

8 Sep 2026

Physics-guided framework doubles digital pathology resolution for cancer screening

Digital pathology relies on high-resolution imaging for accurate cancer diagnosis, yet high-magnification systems remain slow and costly for large-scale screening.

8 Sep 2026

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

Discover how LumiPore improves intracellular delivery with gentle, high-efficiency transfection for drug discovery and cell therapy research.

From Trince 8 Sep 2026

Study reveals evolutionary advantage of human heel-first walking style

The average person takes thousands of steps each day, instinctively walking heel-to-toe. Although they hardly register them, those consistent heel-first strides are more unique to humans than previously thought and allowed early hominins to walk farther more efficiently, but at the cost of higher impact forces on bones and joints, according to a new study led by a researcher at Penn State.

7 Sep 2026

GLP-1 drugs looked promising for depression. The evidence tells a more complicated story

A systematic review of 43 studies found highly heterogeneous results for GLP-1 receptor agonists across animal models and human research assessing depression-, anxiety-, and stress-related outcomes. No study directly tested these drugs as a treatment for PTSD, and the available evidence does not currently support their use for depression or PTSD, although people with metabolic dysfunction may warrant further investigation.

7 Sep 2026

Elusive stem cells offer clues to treat lumbar spinal stenosis

Researchers at Weill Cornell Medicine and Hospital for Special Surgery have discovered the stem cells—unspecialized cells that can develop into specific cell types—that give rise to the body's tendons and ligaments, the tissues connecting muscles and bones.

7 Sep 2026

AI-designed drug candidate reverses biological age in clinical study

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, today announced the publication of a new study conducted in collaboration with an international team of scientists from Harvard Medical School, Stanford University, The Broad Institute, RWTH Aachen University, Peking University and Westlake University.

7 Sep 2026